Michael Chary

Dr. Chary’s research focuses on using artificial intelligence for drug discovery and syndromic surveillance. His overarching goals are to expand medical reasoning beyond the limits of human faculties and to use unstructured data from the Internet to identify spatiotemporal patterns of substance use, disease exposure, and disease manifestation. He uses natural language processing, machine learning, and artificial intelligence to create computational versions of medical and scientific knowledge to allow computers to reason about medicine as experienced clinicians might.

Dr. Chary graduated from New York University, and received his medical degree and doctorate from Mount Sinai School of Medicine. He completed a fellowship in emergency medicine at NewYork-Presbyterian/Queens Hospital and a fellowship in medical toxicology at Boston Children’s Hospital. He is board certified in both medical toxicology and emergency medicine.